๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Qingdao
Clinical trial register · China

Clinical Trials in Qingdao, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Qingdao 7
Narrow the registerReset
Recruitment status
Phase
Site location
Qingdao7
All 1 locations
Target enrolment
to

Trials with a site in Qingdao

7 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions
NCT07090525Overall Response Rate
Qingdao Central Hospital
Phase 2
60
Qingdao
2025-07-01
Active, closed
Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer
NCT07090031EFS, pCR Rate
Qingdao Central Hospital
Phase 2
49
Qingdao
2025-07-01
Recruiting
Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification
NCT07322783EGFR Positive Non-small Cell Lung Cancer, MET Amplification
Qingdao Central Hospital
Phase 2
60
Qingdao
2025-01-01
Recruiting
Nutrition Impact on Immunotherapy of Cancer
NCT06500234Nutrition Disorders, Immunotherapy, Cancer, Survival, Prosthesis
Qingdao Central Hospital
Phase 3
300
Qingdao
2024-06-01
Recruiting
Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer
NCT06514118Small-cell Lung Cancer, Residual Tumor, Radiation
Qingdao Central Hospital
Observational
70
Qingdao
2024-04-17
Recruiting
Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer
NCT06138028Metastatic Esophageal Squamous Cell Carcinoma
Qingdao Central Hospital
Phase 2/3
90
Qingdao
2023-09-20
Not yet open
Colchicine Use for Primary Prevention of Coronary Artery Disease
NCT05175274Coronary Artery Disease
Qingdao Central Hospital
Phase 3
6,792
Qingdao
2022-12-06
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/qingdao

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Qingdao that also match the filters currently applied.

How many clinical trials are recruiting in Qingdao?

5 of the 7 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Qingdao), 7 studies
PhaseStudiesRecruitingShare
Phase 23242.9%
Phase 32128.6%
Observational1114.3%
Phase 2/31114.3%

Most active sponsors

Lead sponsors with the most studies (Qingdao)
Lead sponsorStudiesRecruiting
Qingdao Central Hospital75
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.